Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS)

CNY 16.08

(0.06%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.71 Billion 1.65 Billion 1.76 Billion 1.7 Billion 1.53 Billion 1.25 Billion
Total Current Assets 695.14 Million 780.36 Million 918.81 Million 881.14 Million 720.45 Million 569.77 Million
Cash And Short Term Investments 326.73 Million 320.71 Million 514.76 Million 461.31 Million 327.47 Million 316.29 Million
Cash and Cash Equivalents 323.72 Million 320.71 Million 514.74 Million 461.31 Million 327.47 Million 301.26 Million
Short Term Investments 3.01 Million 10 Million 14.4 Thousand -11.17 Million -8.73 Million 15.02 Million
Net Receivables 119.25 Million 146.57 Million 143.09 Million 118.91 Million 111.12 Million 111.17 Million
Inventory 228.48 Million 292.06 Million 222.08 Million 167.94 Million 174.62 Million 124.81 Million
Other Current Assets 17.26 Million 21 Million 38.86 Million 132.97 Million 107.23 Million 17.48 Million
Total Non-Current Assets 1.02 Billion 874.84 Million 845.99 Million 819.72 Million 812.13 Million 682.93 Million
Net PPE 674.77 Million 561.81 Million 579.95 Million 576.01 Million 577.88 Million 479 Million
Good Will And Intangible Assets 242.72 Million 229.1 Million 166.99 Million 176.49 Million 186.51 Million 139.72 Million
Good Will 10.9 Million 10.9 Million 10.9 Million 10.9 Million 10.9 Million 10.9 Million
Intangible Assets 231.81 Million 218.19 Million 156.08 Million 165.58 Million 175.6 Million 128.81 Million
Long-Term Investments 10.7 Million 60.7 Million 10.68 Million 21.87 Million 9.23 Million -14.52 Million
Tax Assets 889.25 Thousand 5.35 Million 3.38 Million 2.88 Million 3.45 Million 1.86 Million
Other Non Current Assets 94.95 Million 17.86 Million 84.97 Million 42.43 Million 35.04 Million 76.86 Million
Other Assets 0.00 - 1.00 - - -
Total Liabilities 449.19 Million 311.76 Million 427.84 Million 375.8 Million 620.88 Million 424.29 Million
Total Current Liabilities 295.45 Million 295.46 Million 412.49 Million 358.75 Million 371.52 Million 416.84 Million
Account Payables 144.35 Million 175.68 Million 164.63 Million 131.49 Million 162.27 Million 152.48 Million
Tax Payables 10.99 Million 13.8 Million 12.45 Million 26.82 Million 3.97 Million 4.31 Million
Short Term Debt 94.44 Million 33.23 Million 156.3 Million 115.22 Million 105.79 Million 132.35 Million
Deferred Revenue 56.37 Million 8.7 Million 91.24 Million 111.6 Million 100.61 Million 4.31 Million
Other Current Liabilities 286.61 Thousand 77.84 Million 314.43 Thousand 418 Thousand 2.83 Million 127.69 Million
Total Non Current Liabilities 153.74 Million 16.29 Million 15.34 Million 17.04 Million 249.35 Million 7.44 Million
Long-Term Debt 144 Million 304.32 Thousand 870.97 Thousand 1.43 Million 244.45 Million 5 Million
Deferred Revenue Non Current 5.46 Million 7.58 Million 6.94 Million 4.68 Million 1.14 Million 1.25 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - 1.00 1.00 4.48 Million 1.00 -
Other Liabilities 1.00 1.00 - - 1.00 -
Total Equity 1.26 Billion 1.34 Billion 1.33 Billion 1.32 Billion 911.7 Million 828.41 Million
Stock Holders Equity 1.25 Billion 1.32 Billion 1.32 Billion 1.3 Billion 883.81 Million 791.25 Million
Common Stock 171.18 Million 171.18 Million 171.18 Million 171.18 Million 112 Million 112 Million
Retained Earnings 366 Million 430.35 Million 423.42 Million 411.54 Million 247.37 Million 216.98 Million
Accumulated other comprehensive income - 57.25 Million 56.66 Million 52.7 Million 93.08 Million 30.91 Million
Common Stock Equity 1.25 Billion 1.32 Billion 1.32 Billion 1.3 Billion 883.81 Million 791.25 Million
Capital Lease Obligation 304.32 Thousand 304.32 Thousand 870.97 Thousand 1.43 Million - -
Total Investments 10.7 Million 10.7 Million 10.7 Million 10.7 Million 500 Thousand 500 Thousand
Total Debt 238.44 Million 33.53 Million 157.17 Million 115.22 Million 350.25 Million 137.35 Million
Net Debt -85.28 Million -287.18 Million -357.57 Million -346.08 Million 22.78 Million -163.91 Million

Balance Sheet Charts